Dermal Fillers News and Research

RSS

Allergan receives FDA approval to market JUVEDERM ULTRA XC for use in lips

Allergan plc, a leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration to market JUVEDERM ULTRA XC for injection into the lips and perioral area for lip augmentation in adults over the age of 21. JUVEDERM ULTRA XC instantly adds fullness to the lips and is the only dermal filler that has proven results lasting up to one year for lip augmentation.

1 Oct 2015

RepliCel Life Sciences announces final design specifications for next-generation dermal injector

RepliCel Life Sciences Inc., a clinical stage regenerative medicine company, is pleased to announce that the final design specifications of its next-generation dermal injector (RCI-02) have been locked. Prototypes for industrial and regulatory testing will now be built to prepare for an application for CE mark clearance to market the injector in Europe in 2016.

29 Jul 2015

RepliCel obtains two important approvals to conduct RCS-01 phase 1 human clinical trial

RepliCel Life Sciences Inc., a clinical stage regenerative medicine company focused on the development of autologous cell therapies, today announced it has received two important approvals required to conduct its RCS-01 phase 1 human clinical trial.

21 Jul 2015

Galderma obtains FDA approval for Restylane Lyft to restore structure to the cheeks and midface area

Galderma, a global healthcare company focused on skin health, announced today that it has received U.S. Food and Drug Administration approval to market Restylane Lyft for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21.

2 Jul 2015

Aquavit Pharmaceuticals signs licensing agreement with U-Bio Med for microneedle technology

Aquavit Pharmaceuticals, Inc. announces it has signed a definitive licensing agreement with U-Bio Med Inc., a medical technology device company in South Korea, for the worldwide commercialization of the company's microneedle device technology.

19 Jul 2013

Hand rejuvenation therapy effective for reducing damage

We greet each other with our hands, whether with a handshake or a wave. We absentmindedly show off our hands when we reach for something, point somewhere, or just scratch our heads. Our hands are almost always visible and unprotected from the elements.

27 Feb 2012

HA fillers will see highest growth among facial injectable products in 2013 rebound

According to Millennium Research Group, the global authority on medical technology market intelligence, poor economic conditions will limit growth of the European facial injectables market in 2011 and 2012 down to 2.5 percent per year, but the market will rebound strongly in 2013 and onward, reaching a rate of nearly 12 percent by 2016, for a total market of $420 million.

19 Dec 2011

Alliance Data to provide private label credit services to American Laser Centers

Alliance Data Systems Corporation, a leading provider of loyalty and marketing solutions derived from transaction-rich data, today announced it has signed a long-term agreement with American Laser Centers to provide private label credit services designed to drive sales and enhance long-term customer loyalty.

8 Nov 2010

Sculptra dermal filler can make feet feel younger

Most women will sacrifice comfort for fashion, especially when it comes to wearing a gorgeous pair of high heels that make an outfit. Unfortunately, over time, the fat pad at the ball of the foot thins and shifts so bones are not as well padded. Combine these changes with a heel height over two inches and it's a recipe for foot pain. "Now there is an alternative to forsaking your favorite pair of sky high Louboutins, states Dr. Archer.

4 Oct 2010

PROFIT magazine ranks Prollenium as one of Canada's Fastest Growing Companies

Ario Khoshbin, President of Prollenium Medical Technologies Inc., a privately held specialty medical device company, reported today that his firm will continue to record strong year on year gains in revenues and profitability for its 2010 Fiscal Year ending June 30th. Over the past five years, Prollenium has recorded aggregate revenue growth of more than 524% ranking it amongst Canada's fastest growing firms.

13 Aug 2010

Sanofi-aventis signs definitive agreement to acquire assets of Canderm

Sanofi-aventis announced today that it has entered into a definitive agreement under which an affiliate of sanofi-aventis Canada Inc. is to acquire the assets of Canderm Pharma Inc., a privately-held leading Canadian skin care company. This agreement is consistent with the sanofi-aventis Group's global strategy to expand its consumer health care growth platform and follows on the heels of the Group's acquisition of the North American CHC company Chattem Inc. in March 2010.

16 Jun 2010

Artefill: First and only FDA-approved microsphere-enhanced dermal filler for correction of smile lines

Getting older is a fact of life. Looking older doesn't have to be. Patients now have a non-invasive treatment option to reduce the signs of aging and fight wrinkles for good -- with no downtime. Known for their use of the latest technological advancements, Dr. Gilbert Lee and his team at Changes Plastic Surgery & Spa are now using Artefill, the first and only FDA-approved microsphere-enhanced dermal filler for the correction of smile lines, or the lines from your nose to the corners of your mouth.

17 Mar 2010

Study sheds light on how CL-HA stimulates collagen repair in skin

In the U.S. and around the world, the popularity of minimally invasive cosmetic procedures continues to increase. Soft tissue injectables, also known as dermal fillers, are popular procedures that improve the appearance of aging and sun-damaged skin by restoring lost volume and filling lines.

5 Mar 2010

Top ten beauty treatments

RoxSpa, one of the most prestigious and luxurious medi-spas in Beverly Hills, announces their annual 'Top Ten' face and body rejuvenation treatments that are both highly-effective and provide the most satisfying results.

4 Mar 2010

Merz Pharma Group to acquire BioForm Medical

Merz Pharma Group announced today that the subsequent offering period of the tender offer by Merz GmbH & Co. KGaA (“Merz”) and its acquisition subsidiary to purchase all of the outstanding shares of common stock of BioForm Medical, Inc. at a price of $5.45 per share, net to the seller in cash (without interest thereon and less any required withholding tax) expired as scheduled at 12:00 midnight, Eastern Standard Time, on February 18, 2010.

19 Feb 2010

FDA approves Allergan's JUVÉDERM XC dermal filler

Allergan, Inc. today announced the U.S. Food and Drug Administration’s (FDA) approval of JUVÉDERM® XC, a new formulation of the currently FDA-approved JUVÉDERM® dermal filler and the latest advancement in hyaluronic acid (HA) dermal fillers.

1 Feb 2010

Suneva Medical to present interim data from its Artefill study for NLF correction at the Maui Derm 2010

Suneva Medical, a privately-held aesthetic medical device company, today announced 18-month interim results from its prospective, open-label, five-year safety and patient satisfaction study on Artefill for nasolabial fold (NLF) correction. The study assessed adverse events with Artefill starting at 6-months post treatment. Initial results show the incidence of adverse events with Artefill compare favorably to the current label, and that the majority of patients (88%) reported a high satisfaction rating. Upon completion, this will be the largest and longest duration prospective U.S. clinical study of any dermal filler.

27 Jan 2010

Three-day interactive conference to showcase new trendsetting techniques and research in aesthetic plastic surgery

Aesthetic Plastic Surgery: The Next Generation Symposium will be held from December 4-6 at the Waldorf Astoria, announces Z. Paul Lorenc, MD, FACS, New York aesthetic plastic surgeon and Chairman of the APSSNY.

23 Nov 2009

Cosmetic tax unfairly targets women, says New Jersey plastic surgeon

Say hello to Botax, the 5% tax on cosmetic procedures that was a surprise addition to the roughly 2,000 page health care reform bill. The proposed tax, scheduled to take effect January 2010, has been suggested as a way to help fund health care reform.

21 Nov 2009

Suneva Medical commends Trilogy Education for conducting a two-day dermal filler training course for nurses

With the growing use of dermal fillers, ensuring patient safety and satisfaction has never been more important. Dermatology and plastic surgery nurse practitioners continue to play a vital role in managing, educating and interacting with patients. A 2009 study of dermatology nurse practitioners estimates that the average number of patients nurse practitioners see each year totals six hundred million.

13 Nov 2009